Ex Vivo News and Research

RSS

New method to grow embryonic stem cells on a microfluidic chip

It's no surprise that using human embryos for biological and medical research comes with many ethical concerns. Correct though it is to proceed with caution in these matters, the fact is that much science would benefit from being able to study human biology more accurately.

29 Jun 2019

Making Bacterial Infections a Thing of the Past for Chronic Respiratory Conditions

In this interview, Prof. Elborn and Dr. Dixon discuss the issues involving chronic lung conditions such as cystic fibrosis and bacterial respiratory infections.

From Neem Biotech 25 Jun 2019

Blood stem cell breakthrough could spare some patients from side effects of cancer treatments

A method of growing blood stem cells in the laboratory has been developed by researchers at Stanford University and the University of Tokyo, in a breakthrough that could spare some people with blood and immune disorders from the side effects of intensive chemotherapy and radiotherapy.

31 May 2019

Manuka honey could be useful in treating cystic fibrosis lung infection

Researchers at the Swansea University have shown that Manuka honey could be useful in treatment of deadly lung infections caused by antimicrobial resistant respiratory bacteria in cystic fibrosis (CF). The study titled, “Anti-pseudomonad Activity of Manuka Honey and Antibiotics in a Specialized ex vivo Model Simulating Cystic Fibrosis Lung Infection,” was published in the latest issue of the journal Frontiers of Microbiology.

30 May 2019

NIH-funded trial demonstrates safety of potential treatment in lung transplant patients

A new study, presented today at the American Association for Thoracic Surgery's 99th Annual Meeting, shows that a potential treatment for ischemia- reperfusion injury is safe for humans.

6 May 2019

Experts to present tumor DNA, breast and jaw reconstruction studies at PSRC annual meeting

The Plastic Surgery Research Council focuses on awareness surrounding compelling research relating to the field of plastic surgery.

3 May 2019

Novel chemical probe enables live imaging of brain immune cells

Researchers in South Korea and Singapore have, for the first time, developed a chemical probe that enables live-imaging of a type of immune cells in the brain, known as microglia, in a live animal brain.

3 May 2019

Breakthrough antibody treatment suppresses HIV without antivirals

A new research paper describes how an antibody that prevents HIV binding to human immune cells was shown to be able to suppress levels of HIV for up to four months.

18 Apr 2019

New technique uses UV and red light to decontaminate organs before transplantation

A new technique for the decontamination of organs before transplantation using ultraviolet and red light irradiation has been developed by Brazilian and Canadian researchers and is described in an article published in the journal Nature Communications.

12 Apr 2019

Repurposing drugs to outsmart cancers

In an article published today by SAGE Publishing, investigators from The Nagourney Cancer Institute and The Albert Einstein Israelite Hospital in São Paulo, Brazil, announced a new approach to identifying effective treatments for patients with advanced metastatic cancers. A drug commonly used to treat kidney and liver cancer was discovered effective for breast cancer, which may open new drug therapies to patients regardless of tumor type.

22 Mar 2019

Open-source solution for multiparametric optical mapping of the heart's electrical activity

An international research team from the George Washington University, U.S., and the Moscow Institute of Physics and Technology, Russia, has developed an open-source solution for multiparametric optical mapping of the heart's electrical activity.

22 Mar 2019

Anti-cancer immunotherapy could be used to fight HIV

Researchers at the University of Montreal Hospital Research Centre have shown that immunotherapy treatments against cancer could reduce the amount of virus that persists in people on triple therapy.

19 Feb 2019

New study seeks to understand how colibactin causes cancer

For more than a decade, scientists have worked to understand the connection between colibactin, a compound produced by certain strains of E. coli, and colorectal cancer, but have been hampered by their inability to isolate the compound.

15 Feb 2019

Bruker launches new SKYSCAN 1273 benchtop 3D X-ray microscope

Bruker today announced the new SKYSCAN 1273 benchtop 3D X-ray microscope based on micro-computed tomography technology.

From Bruker BioSpin Division 6 Feb 2019

New automated, high-throughput bioreactor system for lung regeneration analysis

New strides are being made toward the ex vivo growth of human lungs. In a new article published in Tissue Engineering, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers, researchers report the development of a high-throughput, automated, multichannel lung bioreactor that allows parallel culture of up to five human cell-populated isolated rat lung scaffolds.

29 Jan 2019

Sartorius launches BIOSTAT RM TX single-use bioreactor for consistent quality cellular products

Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry today announced the launch of the BIOSTAT RM TX single-use bioreactor, a new wave mixed system developed specifically for closed, automated expansion of consistent quality cell products such as ex vivo cellular immunotherapies.

From Sartorius 22 Jan 2019

Neuroscientists decipher how brain circuits optimize themselves

Human beings, like other animals, possess an enormous learning capacity that allows for the apprehension of new sensory information to master new skills or to adapt to an ever-changing environment.

2 Jan 2019

New approach to destroy HIV reservoirs

Current HIV treatments need to be taken for life by those infected as antiretroviral therapy is unable to eliminate viral reservoirs lurking in immune cells. Institut Pasteur scientists have identified the characteristics of CD4 T lymphocytes that are preferentially infected by the virus - it is their metabolic (or energy-producing) activity1 that enables the virus to multiply.

21 Dec 2018

Potential combination therapy against rare disease of the bone marrow could improve treatment

Myelofibrosis is a severe and very rare hematological disease for which treatment has only been partially effective to date. Its low incidence rate is one of the reasons why effective therapies are still lacking.

19 Dec 2018

Study identifies specific neurological changes related to traumatic brain injury

Traumatic brain injury, or TBI, is often referred to as the "invisible injury" - while on the surface everything seems normal with brain structure, symptoms may present themselves in the behavior of the injured and cannot be explained.

17 Dec 2018